The brochure with the 2-day conference agenda ... the ninth session of the SMi’s Annual Orphan Drugs and Rare Diseases Conference will bring together experts from across the vibrant rare ...

Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and brain-related health conditions, today announced the submission of its Investigator’s ...